Tata Nifty MidSmall Healthcare Index Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.64% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
Rating
Not Rated
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹208 Cr
Created on
5 April 2024
Fund Ranking
#
/ 16 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
6 Month
20.2%
1 Year
16.8%
3 Year (CAGR)
-
All Time (CAGR)
19.1%
Category Return
6 Month
17.3%
1 Year
16.6%
3 Year (CAGR)
20.9%
All Time (CAGR)
17.1%
Asset Allocation
Equity
100.0%
Other
-0.0%
Top 5 Holdings
Top 5 Sectors
Aurobindo Pharma
6.99%
Ipca Laboratories
3.74%
JB Chemicals
2.98%
Abbott India
2.10%
Lupin
9.30%
Fund Information
Expense Ratio
1.12%
Exit Load
No Exit Load
Lock-In Period
No Lock-In
Managed By
Nitin Bharat Sharma
July 2025 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.00
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
0.00
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
0.00
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.